AAAAAA

   
Results: 1-11 |
Results: 11
Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregationinduced by different agonists in human whole blood
Authors: Storey, RF Newby, LJ Heptinstall, S
Citation: Rf. Storey et al., Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregationinduced by different agonists in human whole blood, PLATELETS, 12(7), 2001, pp. 443-447
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro
Authors: Zhao, L Bath, P Heptinstall, S
Citation: L. Zhao et al., Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro, BR J PHARM, 134(2), 2001, pp. 353-358
Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function
Authors: Natarajan, P May, JA Sanderson, HM Zabe, M Spangenberg, P Heptinstall, S
Citation: P. Natarajan et al., Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function, PLATELETS, 11(8), 2000, pp. 467-476
The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
Authors: Storey, RF Sanderson, HM White, AE May, JA Cameron, KE Heptinstall, S
Citation: Rf. Storey et al., The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity, BR J HAEM, 110(4), 2000, pp. 925-934
Unexpected changes in the catecholamine content of platelets and plasma during exercise
Authors: Peirce, NS Forster, CD Heptinstall, S Macdonald, IA
Citation: Ns. Peirce et al., Unexpected changes in the catecholamine content of platelets and plasma during exercise, PLATELETS, 10(5), 1999, pp. 312-318
Increased platelet activation in renal transplant patients
Authors: Taylor, JE Porter, C Heptinstall, S McLaren, M Belch, JJF
Citation: Je. Taylor et al., Increased platelet activation in renal transplant patients, PLATELETS, 10(4), 1999, pp. 223-227
A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: Comparison with other aggregation methodologies
Authors: Storey, RF May, JA Wilcox, RG Heptinstall, S
Citation: Rf. Storey et al., A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: Comparison with other aggregation methodologies, THROMB HAEM, 82(4), 1999, pp. 1307-1311
Comparison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis
Authors: Brown, N May, JA Wilcox, RG Allan, LM Wilson, AM Kiff, PS Heptinstall, S
Citation: N. Brown et al., Comparison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis, BR J CL PH, 48(1), 1999, pp. 57-62
Protection of human gastric mucosa against aspirin - enteric coating or dose reduction?
Authors: Cole, AT Hudson, N Liew, LCW Murray, FE Hawkey, CJ Heptinstall, S
Citation: At. Cole et al., Protection of human gastric mucosa against aspirin - enteric coating or dose reduction?, ALIM PHARM, 13(2), 1999, pp. 187-193
Laboratory investigation of platelet function
Authors: Storey, RF Heptinstall, S
Citation: Rf. Storey et S. Heptinstall, Laboratory investigation of platelet function, CLIN LAB H, 21(5), 1999, pp. 317-329
Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice?
Authors: Heptinstall, S White, A Edwards, N Pascoe, J Sanderson, HM Fox, SC Henderson, RA
Citation: S. Heptinstall et al., Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice?, BR J HAEM, 103(4), 1998, pp. 1023-1030
Risultati: 1-11 |